Peptides have moved from niche bodybuilding forums into mainstream conversations about knee pain, post-surgical healing, and joint longevity
Structure and symmetry inform gating principles of ionotropic glutamate receptors
We are not currently accepting new orders
Randomized clinical trial of 12% and 38% silver diamine fluoride treatment
The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2
Shop high-demand research peptides including BPC-157, TB-500, GLP-3 (R), GLP-2 (T), GLP-1 (S), NAD+, Tesamorelin, CJC/Ipamorelin, GHK-Cu, and more
